Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2026-04-20 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
第三届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 21st meeting of the third board of directors of Huizhou Jin Hao Medical Technology Co., Ltd. It includes information about the meeting's attendance, the agenda items discussed, and the voting results. The document references multiple reports and announcements (such as the 2025 Annual Report, Audit Report, Internal Control Report, and others) that are disclosed separately on the Beijing Stock Exchange information disclosure platform. The document itself does not contain the full reports or financial data but rather summarizes the board's approval of these reports and other corporate matters. This type of document is a formal announcement of board meeting resolutions, which fits the category of Board/Management Information (MANG). It is not the full annual report, audit report, or any other detailed report but an announcement of board decisions and approvals.
2026-04-20 Chinese
2025年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2025年度内部控制评价报告' which translates to '2025 Internal Control Evaluation Report' issued by the company's board. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2025, including detailed descriptions of internal control scope, standards, and conclusions. It is a standalone report focused on internal control evaluation rather than a full annual report or audit report. The document length is 3132 characters, which is relatively short but contains substantive content about internal control evaluation, not just an announcement or certification. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and internal control evaluation results, excluding full annual reports. Therefore, the appropriate classification is AR with high confidence.
2026-04-20 Chinese
2025年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' (Audit Report) issued by a certified public accounting firm for 惠州市锦好医疗科技股份有限公司. It contains detailed audit opinions, basis for audit opinions, key audit matters, management responsibilities, and auditor responsibilities. The report covers the financial statements for the fiscal year ending December 31, 2025, including consolidated and parent company balance sheets, profit and loss statements, and notes. The presence of detailed audit procedures, audit opinion, and financial statement data confirms this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains the full audit report text, not just an announcement or certification. Therefore, the correct classification is Audit Report / Information (AR).
2026-04-20 Chinese
2025年度董事会审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2025年度董事会审计委员会履职情况报告" which translates to the "2025 Annual Report on the Board Audit Committee's Performance." It details the audit committee's activities, meetings, evaluations of internal and external audits, internal control assessments, and coordination with management and auditors. The document is a report on the audit committee's work and oversight rather than a full annual report or standalone audit report. It does not contain full financial statements or detailed financial results but focuses on the audit committee's duties and evaluations. This type of document fits best under the category of Audit Report / Information (AR), which includes reports on audit committee activities, audit results, and internal control assessments, excluding full annual reports. The document length is 2680 characters, which is consistent with a detailed committee report rather than a brief announcement or a full annual report. Therefore, the classification is AR with high confidence.
2026-04-20 Chinese
2025年度董事会工作报告
Management Reports Classification · 95% confidence The document is titled '2025年度董事会工作报告' which translates to '2025 Annual Board of Directors Work Report'. It contains detailed information about the board's activities, governance, meetings, resolutions passed, performance, and future plans. It includes financial performance summaries but is primarily focused on the board's work and governance rather than full financial statements or audit opinions. The document is over 6,000 characters, indicating it is a substantive report rather than a brief announcement. The content aligns with a Management Reports category, which covers management's detailed explanation of financial results, business trends, and outlook, as well as governance and board activities. It is not an Annual Report (10-K) because it lacks comprehensive financial statements and audit reports. It is not an Audit Report (AR) or Earnings Release (ER) because it is broader and more detailed about board work. Therefore, the best fit is Management Reports (MDA).
2026-04-20 Chinese
董事、高级管理人员薪酬方案的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding the 2026 remuneration scheme for the company's directors and senior management. It details the salary structure, performance pay, and long-term incentives for these individuals. It also describes the approval process and related board meetings. There are no financial statements or performance data included, nor is this a report of actual compensation paid. Instead, it is a disclosure of the remuneration policy and scheme for the upcoming year. This fits the definition of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2026-04-20 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.